2.2. Inclusion criteria
CLD, thrombocytopenia
THROMBOCYTOPENIA, CLD
All patients enrolled were ≥ 18 years, had thrombocytopenia associated with CLD and were planned to undergo, or underwent, treatment with avatrombopag prior to a procedure. For retrospective enrollment (patients enrolled and consented after procedure day) patients must have had, at a minimum, a platelet count from approximately 7 days prior to starting avatrombopag and a platelet count on the procedure day, to enable evaluation of study endpoints. All patients provided written informed consent and there were no exclusion criteria for participation in this observational study, including no exclusion of patients for concomitant medications before or during the study.